Regions Financial Corp’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.71M Buy
12,245
+1,775
+17% +$249K 0.01% 394
2025
Q4
$1.29M Buy
10,470
+1,078
+11% +$131K 0.01% 446
2025
Q3
$1.04M Buy
9,392
+122
+1% +$13.9K 0.01% 490
2025
Q2
$1.03M Sell
9,270
-1,662
-15% -$177K 0.01% 483
2025
Q1
$1.22M Sell
10,932
-995
-8% -$103K 0.01% 442
2024
Q4
$1.1M Buy
11,927
+243
+2% +$21.9K 0.01% 462
2024
Q3
$980K Sell
11,684
-514
-4% -$39.2K 0.01% 495
2024
Q2
$837K Sell
12,198
-5,103
-29% -$341K 0.01% 503
2024
Q1
$1.27M Sell
17,301
-1,040
-6% -$80K 0.01% 452
2023
Q4
$1.49M Sell
18,341
-1,646
-8% -$128K 0.01% 413
2023
Q3
$1.5M Sell
19,987
-192
-1% -$14.8K 0.01% 392
2023
Q2
$1.56M Sell
20,179
-1,612
-7% -$129K 0.01% 405
2023
Q1
$1.81M Sell
21,791
-899
-4% -$74.5K 0.02% 373
2022
Q4
$1.95M Buy
22,690
+536
+2% +$42.4K 0.02% 342
2022
Q3
$1.37M Sell
22,154
-481
-2% -$30.3K 0.01% 410
2022
Q2
$1.4M Sell
22,635
-1,954
-8% -$121K 0.01% 417
2022
Q1
$1.46M Sell
24,589
-154
-0.6% -$9.84K 0.01% 438
2021
Q4
$1.8M Sell
24,743
-2,424
-9% -$167K 0.01% 411
2021
Q3
$1.9M Sell
27,167
-2,393
-8% -$168K 0.02% 382
2021
Q2
$2.04M Sell
29,560
-12,950
-30% -$865K 0.02% 366
2021
Q1
$2.75M Sell
42,510
-15,095
-26% -$973K 0.02% 296
2020
Q4
$3.36M Sell
57,605
-17,139
-23% -$1.03M 0.03% 255
2020
Q3
$4.72M Sell
74,744
-10,901
-13% -$756K 0.05% 196
2020
Q2
$6.59M Sell
85,645
-64,884
-43% -$4.97M 0.08% 162
2020
Q1
$11.3M Sell
150,529
-531,666
-78% -$36.7M 0.15% 130
2019
Q4
$44.3M Sell
682,195
-17,541
-3% -$1.14M 0.47% 62
2019
Q3
$44.4M Buy
699,736
+30,401
+5% +$1.99M 0.49% 63
2019
Q2
$45.2M Buy
669,335
+27,885
+4% +$1.83M 0.51% 61
2019
Q1
$41.7M Buy
641,450
+133,381
+26% +$8.87M 0.48% 68
2018
Q4
$31.8M Buy
508,069
+412,133
+430% +$28.8M 0.4% 78
2018
Q3
$7.41M Buy
95,936
+17,254
+22% +$1.3M 0.08% 168
2018
Q2
$5.57M Buy
78,682
+8,882
+13% +$627K 0.06% 185
2018
Q1
$5.26M Sell
69,800
-2,555
-4% -$203K 0.06% 189
2017
Q4
$5.18M Buy
72,355
+1,813
+3% +$138K 0.06% 188
2017
Q3
$5.71M Sell
70,542
-2,570
-4% -$197K 0.06% 178
2017
Q2
$5.17M Buy
73,112
+997
+1% +$66.3K 0.06% 187
2017
Q1
$4.9M Sell
72,115
-5,467
-7% -$384K 0.06% 187
2016
Q4
$5.56M Sell
77,582
-7,671
-9% -$570K 0.07% 173
2016
Q3
$6.75M Sell
85,253
-8,759
-9% -$712K 0.09% 161
2016
Q2
$7.84M Sell
94,012
-13,014
-12% -$1.15M 0.1% 153
2016
Q1
$9.83M Sell
107,026
-6,356
-6% -$573K 0.13% 140
2015
Q4
$11.5M Sell
113,382
-16,616
-13% -$1.73M 0.15% 136
2015
Q3
$12.8M Sell
129,998
-59,974
-32% -$6.66M 0.18% 125
2015
Q2
$22.2M Sell
189,972
-153,451
-45% -$16.8M 0.3% 99
2015
Q1
$33.7M Sell
343,423
-32,671
-9% -$3.32M 0.43% 81
2014
Q4
$35.5M Sell
376,094
-106,523
-22% -$11M 0.46% 69
2014
Q3
$51.4M Sell
482,617
-35,143
-7% -$3.44M 0.64% 43
2014
Q2
$42.9M Buy
517,760
+23,530
+5% +$1.83M 0.53% 51
2014
Q1
$35M Buy
494,230
+85,194
+21% +$6.68M 0.44% 72
2013
Q4
$30.7M Buy
409,036
+8,366
+2% +$583K 0.38% 84
2013
Q3
$25.2M Buy
400,670
+185,990
+87% +$11.1M 0.33% 92
2013
Q2
$11M Buy
+214,680
New +$11.2M 0.15% 126

Other funds holding GILD

Regions Financial Corp's GILD Position: Q1 2026 in Review

Regions Financial Corp increased its Gilead Sciences (GILD) stake by 17% in Q1 2026, buying an estimated $249K and bringing the position to 12,245 shares worth $1.71M. The position accounts for 0.01% of the portfolio, ranked #394.

Regions Financial Corp first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $51.4M in Q3 2014. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Regions Financial Corp held 12,245 shares of Gilead Sciences worth $1.71M as of Q1 2026.
  • Regions Financial Corp bought 1,775 Gilead Sciences shares in Q1 2026, an estimated $249K.
  • Gilead Sciences made up 0.01% of Regions Financial Corp's portfolio in Q1 2026, its #394 holding.
  • Regions Financial Corp first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • Regions Financial Corp's Gilead Sciences position peaked at $51.4M in Q3 2014.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Regions Financial Corp's 13F filing for Q1 2026, filed 5 May 2026.